Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 587,500 shares, an increase of 7.4% from the April 15th total of 547,200 shares. Currently, 2.7% of the company’s shares are short sold. Based […]
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) – Equities researchers at HC Wainwright decreased their FY2024 earnings per share (EPS) estimates for shares of Eton Pharmaceuticals in a research note issued to investors on Friday, May 12th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn $0.15 per share for the year, […]
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 587,500 shares, an increase of 7.4% from the April 15th total of 547,200 shares. Approximately 2.7% of the shares of the company are short sold. Based on […]
Should You Buy or Sell Eton Pharmaceuticals Stock? Get The Latest ETON Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 518,300 shares, a growth of 11.0% from the February 28th total of 467,100 shares. Based on an average daily volume of 67,200 shares, the […]